New avenues for the optimzation of dendritic cell-based cancer immunotherapies
A recent study reveals that inhibiting certain adhesion receptors on the surface of dendritic cells, the main antigen-presenting cells of the immune system, enhances antitumor responses.
Read Original Article: New avenues for the optimzation of dendritic cell-based cancer immunotherapies »
